Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endotheliam growth factor receptors
The demonstration that angiogenesis is required for the growth of solid tumors has fueled an intense interest in the development of new therapeutic strategies that target the tumor vasculature. Here we report the development of an immune-based antiangiogenic strategy that is based on the generation...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 99; no. 10; p. 7009 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Washington
National Academy of Sciences
14.05.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!